Nuclein, LLC
AUSTIN, TX · Founded 2017 · CIK 0001787352 · Medtech · Private
Point-of-care PCR system for rapid nucleic acid testing
nuclein.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.5M
- 9 Form D · Jun 2026
- 4 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 16
- 3 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $420,012 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $750,000 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $1,295,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 787 | Onexio Biosystems LLC | — | — |
| 788 | Operational Techologies Corporation | — | — |
| 789 | SUBTLE TECHNOLOGY LLC | — | — |
| 790 | Nuclein, LLC | — | $2.5M |
| 791 | Innovative Biotherapies, Inc. | — | — |
| 792 | SAFETYSPECT, INC. | — | $106K |
| 793 | KoKo Medical, Inc. | — | $27M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alan BlakeDirector · Executive Officer
- Douglas BryantDirector
- John ButlerDirector
- Sanjay ChandraDirector
- Richard CrockettDirector · Executive Officer
- William CunninghamDirector
- Walter NarajowskiDirector
- David ShockleyDirector
- H. ShockleyDirector
- Jeffrey StukulsExecutive Officer
Patents
- Apparatus And Methods For Molecular Diagnosticsgranted
- Apparatus And Methods For Molecular Diagnosticsgranted
- Analyte Detection Cartridge And Methods Of Use Thereofapplication
- Direct Lysis Apparatus And Methods For Molecular Diagnosticsapplication
- Apparatus And Methods For Molecular Diagnosticsapplication
- Molecular Diagnostic Devicegranted
- Direct Lysis Apparatus And Methods For Molecular Diagnosticsapplication
- Apparatus And Methods For Molecular Diagnosticsapplication
- Apparatus And Methods For Molecular Diagnosticsapplication
- Apparatus And Methods For Molecular Diagnosticsapplication
- Apparatus And Methods For Molecular Diagnosticsapplication
- Apparatus And Methods For Molecular Diagnosticsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.